Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
16 Jun, 2026, 02.24 PM IST
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
15 Jun, 2026, 11.08 AM IST
The accounting trick used by companies to make a weak balance sheet look strongIn one recent case, a large investment sat comfortably under equity until the auditor read the shareholders' agreement, found a buyback cla...
12 Jun, 2026, 06.46 PM IST
On This Day in History, June 10: Troy falls, Italy enters WWII, Jurassic Park premieres, Thatcher wins for 3rd time, FIFA World Cup opens and other key eventsOn This Day in History, June 10 witnessed events that ranged from the legendary destruction of Troy and the birth of Gothic architecture to...
10 Jun, 2026, 10.35 PM IST
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
02 Jun, 2026, 03.30 PM IST
AI to turbocharge patent creation at India tech hubs, executives sayIndian technology hubs are becoming major innovation centers. Global companies anticipate AI will speed up new product and intellectual pro...
27 May, 2026, 07.25 PM IST
German firm B+H Solutions to invest 1 mn euro in India to expand nano-fertiliser businessGerman agritech firm B+H Solutions GmbH plans to invest €1 million in India in 2026 to expand its footprint in the country's growing agricu...
25 May, 2026, 12.52 PM IST
Desi chip companies fear MNCs will dip into their DLI 2.0 treatIndia is planning the second phase of its semiconductor incentive scheme, DLI 2.0. Concerns are rising among domestic startups that allowin...
21 May, 2026, 06.00 AM IST
Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
20 May, 2026, 08.06 PM IST
India's Rs 1.7 lakh crore fuel crisis may have found an unlikely fixIndia faces high energy import costs and a weakening ₹. A Monaco company, FOWE Eco Solutions, presents a water-based fuel emulsion technolo...
17 May, 2026, 08.35 PM IST
88% ‘hard-to-recycle’ plastic: PolyCycl’s bet on turning waste into valueIndia's plastic waste problem is being tackled by PolyCycl's innovative chemical recycling. The technology transforms difficult-to-recycle ...
01 May, 2026, 10.58 AM IST
Anand Mahindra finds Monday motivation in grandfather’s forgotten crude oil engine patent, which he was not aware ofAnand Mahindra Monday Motivation: Mahindra Group Chairman Anand Mahindra discovered a 1918 patent by his grandfather, J.C. Mahindra, for a ...
27 Apr, 2026, 10.21 AM IST
The Long Drive: 14 decades of the automobile that changed how we travelFourteen decades, countless journeys and one invention that changed humanity. Atul Bandekar takes us on a ride through the story of the aut...
26 Apr, 2026, 09.28 AM IST
SBI seeks Supreme Court review of spectrum ruling in Aircel case, warns of banking and IBC risksSBI has moved the Supreme Court seeking review of its February 13 ruling that barred telecom spectrum from being treated as an asset under ...
22 Apr, 2026, 12.51 AM IST
Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
16 Apr, 2026, 07.31 AM IST
Patent application filings in India rise 30.2% to 1.43 lakh in 2025-26: GoyalIndia's patent filings reached a historic high of over 1.43 lakh in FY 2025-26, a 30.2% jump. Domestic innovators led this surge, with Tami...
12 Apr, 2026, 03.57 PM IST
- Pharma industry split over nod to Natco to sell Bayer's cancer drug
The decision to allow Natco Pharma to sell Bayer's patented cancer drug Nexavar has divided the pharmaceutical industry.
13 Mar, 2012, 04.51 PM IST